Opaleye Management Inc. Journey Medical Corp Transaction History

Opaleye Management Inc.

  • $548 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.46 - $4.15 $33,357 - $56,274
13,560 Added 5.52%
259,293 $638,000
Q2 2022

Aug 15, 2022
BUY
$2.62 - $5.06 $468,280 - $904,388
178,733 Added 266.77%
245,733 $919,000
Q1 2022

May 16, 2022
BUY
$3.93 - $5.76 $263,310 - $385,920
67,000 New
67,000 $324,000

Others Institutions Holding DERM

# of Institutions
39
Shares Held
2.93M
Call Options Held
0
Put Options Held
0
View Full List

About Journey Medical Corp

DERM Quotes by TradingView
  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $44.1M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email